Posttranscriptional modification of retroviral primers is required for late stages of DNA replication

被引:20
作者
Burnett, BP [1 ]
McHenry, CS [1 ]
机构
[1] UNIV COLORADO,HLTH SCI CTR,PROGRAM MOL BIOL,DENVER,CO 80262
关键词
reverse transcription; strand transfer; HIV; tRNA;
D O I
10.1073/pnas.94.14.7210
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
During reverse transcription of retroviral RNA, synthesis of (-) strand DNA is primed by a cellular tRNA that anneals to an 18-nt primer binding site within the 5' long terminal repeat. For (+) strand synthesis using a (-) strand DNA template linked to the tRNA primer, only the first 18 nt of tRNA are replicated to regenerate the primer binding site, creating the (+) strand strong stop DNA intermediate and providing a 3' terminus capable of strand transfer and further elongation. On model HIV templates that approximate the (-) strand linked to natural modified or synthetic unmodified tRNA(3)(Lys), we find that a (+) strand strong stop intermediate of the proper length is generated only on templates containing the natural, modified tRNA(3)(Lys), suggesting that a posttranscriptional modification provides the termination signal. In the presence of a recipient template, synthesis after strand transfer occurs only from intermediates generated from templates containing modified tRNA(3)(Lys). Reverse transcriptase from Moloney murine leukemia virus and avian myoblastosis virus shows the same requirement for a modified tRNA(3)(Lys) template. Because all retroviral tRNA primers contain the same 1-methyl-A(58) modification, our results suggest that 1-methyl-A(58) is generally required for termination of replication 18 nt into the tRNA sequence, generating the (+) strand intermediate, strand transfer, and subsequent synthesis of the entire (+) strand. The possibility that the host methyl transferase responsible for methylating A(58) may provide a target for HIV chemotherapy is discussed.
引用
收藏
页码:7210 / 7215
页数:6
相关论文
共 46 条
  • [1] ABBOTTS J, 1993, J BIOL CHEM, V268, P10312
  • [2] BEBENEK K, 1993, REVERSE TRANSCRIPTAS, P85
  • [3] Molecular analysis of the second template switch during reverse transcription of the HIV RNA template
    BenArtzi, H
    Shemesh, J
    Zeelon, E
    Amit, B
    Kleiman, L
    Gorecki, M
    Panet, A
    [J]. BIOCHEMISTRY, 1996, 35 (32) : 10549 - 10557
  • [4] VIRAL-DNA SYNTHESIZED INVITRO BY AVIAN RETROVIRUS PARTICLES PERMEABILIZED WITH MELITTIN .1. KINETICS OF SYNTHESIS AND SIZE OF MINUS-STRAND AND PLUS-STRAND TRANSCRIPTS
    BOONE, LR
    SKALKA, AM
    [J]. JOURNAL OF VIROLOGY, 1981, 37 (01) : 109 - 116
  • [5] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS
    BOUCHER, CAB
    OSULLIVAN, E
    MULDER, JW
    RAMAUTARSING, C
    KELLAM, P
    DARBY, G
    LANGE, JMA
    GOUDSMIT, J
    LARDER, BA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 105 - 110
  • [6] MECHANISM OF RNA PRIMER REMOVAL BY THE RNASE-H ACTIVITY OF AVIAN-MYELOBLASTOSIS VIRUS REVERSE-TRANSCRIPTASE
    CHAMPOUX, JJ
    GILBOA, E
    BALTIMORE, D
    [J]. JOURNAL OF VIROLOGY, 1984, 49 (03) : 686 - 691
  • [7] A SINGLE-STRANDED GAP IN HUMAN-IMMUNODEFICIENCY-VIRUS UNINTEGRATED LINEAR DNA DEFINED BY A CENTRAL COPY OF THE POLYPURINE TRACT
    CHARNEAU, P
    CLAVEL, F
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (05) : 2415 - 2421
  • [9] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
    COFFIN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 483 - 489
  • [10] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
    CONDRA, JH
    SCHLEIF, WA
    BLAHY, OM
    GABRYELSKI, LJ
    GRAHAM, DJ
    QUINTERO, JC
    RHODES, A
    ROBBINS, HL
    ROTH, E
    SHIVAPRAKASH, M
    TITUS, D
    YANG, T
    TEPPLER, H
    SQUIRES, KE
    DEUTSCH, PJ
    EMINI, EA
    [J]. NATURE, 1995, 374 (6522) : 569 - 571